LONGBOARD PHARMACEUTICALS

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark LONGBOARD PHARMACEUTICALS was filed as Word mark on 03/30/2021 at the World Intellectual Property Organization.

Trademark Details Last update: August 11, 2023

Trademark form Word mark
File reference 1594765
Countries Australia Brazil Canada Switzerland China European Community United Kingdom Israel India Japan South Korea Mexico New Zealand Russia Turkey
Base trademark US No. 90232106, October 2, 2020
Application date March 30, 2021
Expiration date March 30, 2031

Trademark owner

4275 Executive Square, Suite 950
La Jolla CA 92037
US

Trademark representatives

151 West 42nd Street, 17th Floor New York NY 10036 US

goods and services

05 Pharmaceutical preparations for human use; biological preparations for human use; pharmaceutical preparations and pharmaceutical compounds for the treatment of disorders of the central nervous system; biological preparations for the treatment of disorders of the central nervous system
42 Scientific and technological services, namely, medical research, scientific research and analysis in the field of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, biologics, clinical trials and post-market trials; research and development services in the fields of pharmaceuticals, biologics and biotechnology; scientific research and development; laboratory research, screening, evaluation, development and clinical testing of therapeutic compounds; scientific research, studies, and development in the field of pharmaceuticals and biologics; scientific research and development, namely, pharmaceutical discovery, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development
44 Providing medical information

Trademark history

Date Document number Area Entry
March 2, 2023 2023/12 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 24, 2022 2022/46 Gaz US RAW: Partial Ceasing Effect
September 16, 2022 2022/38 Gaz CA Rejection
August 1, 2022 2022/31 Gaz MX Rejection
July 20, 2022 2022/29 Gaz KR Rejection
May 17, 2022 2022/25 Gaz BR Rejection
May 11, 2022 2022/20 Gaz CH Rejection
March 17, 2022 2022/12 Gaz JP Rejection
February 28, 2022 2022/9 Gaz TR Rejection
November 30, 2021 2021/48 Gaz NZ Rejection
November 24, 2021 2021/47 Gaz IN Rejection
November 16, 2021 2021/46 Gaz CN Rejection
October 20, 2021 2021/42 Gaz EM Rejection
October 20, 2021 2021/42 Gaz GB Rejection
October 13, 2021 2021/42 Gaz IL Rejection
August 30, 2021 2021/35 Gaz RU Rejection
August 24, 2021 2021/34 Gaz AU Rejection
March 30, 2021 2021/20 Gaz US Registration

ID: 141594765